Trial
NCT05228834
Voxelotor Neurocognitive Function Study
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Pfizer
Collaborators
—
Condition
Sickle Cell Disease
Intervention
Voxelotor Only Product in Oral Dose Form
Why stopped
Data will not inform further development of Voxelotor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-02